NCT04437680 is a clinical trial of Votiva device in Vulvovaginal Signs and Symptoms, sponsored by InMode MD Ltd..

Who is sponsoring NCT04437680?

NCT04437680 is sponsored by InMode MD Ltd..

What drugs are being tested in NCT04437680?

Interventions in NCT04437680: Votiva device.

What condition does NCT04437680 study?

NCT04437680 studies Vulvovaginal Signs and Symptoms.

Is NCT04437680 still recruiting?

NCT04437680 is currently completed. Last updated 11 January 2022.

Last reviewed 2022-01-11 · How we verify

NCT04437680

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Retrospective Chart Review Study of Patients Treated With Votiva Device

Completed Last updated 11 January 2022

What this trial tests

trial testing Votiva device in Vulvovaginal Signs and Symptoms in 600 participants. Completed in 30 December 2020.

Timeline

5 June 2020

Primary endpoint
30 December 2020

30 December 2020

Quick facts

Lead sponsor	InMode MD Ltd.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	600
Start date	5 June 2020
Primary completion	30 December 2020
Estimated completion	30 December 2020
Sites	2 locations across United States

Drugs / interventions tested

Votiva device

Conditions studied

Vulvovaginal Signs and Symptoms — all drugs for Vulvovaginal Signs and Symptoms →

Sponsor

InMode MD Ltd.

Who can join

18 and older, female only, with Vulvovaginal Signs and Symptoms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

retrospective data collection is to gain insight into patients satisfaction post Votiva treatments for the complex of vulvovaginal symptoms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Vulvovaginal Signs and Symptoms

Currently open trials in the same condition.

NCT07023822 — WISH, Feasibility of a Factorial Design · NA · active not recruiting

Other InMode MD Ltd. trials

Trials by the same sponsor.

NCT07209397 — Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women · NA · recruiting
NCT06283498 — Transvaginal Detrusor Nerve Radiofrequency Ablation for Treatment of Overactive Bladder · NA · enrolling by invitation
NCT06458556 — Transvaginal Radiofrequency Ablation for Overactive Bladder · NA · completed
NCT05830968 — Safety and Efficacy of Radio Frequency for the Treatment of Mild to Severe Inflammatory Acne · NA · recruiting
NCT06283056 — RF Microneedling With Multi-Depth Targeting Per Insertion for The Treatment of Cellulite · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04437680 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by InMode MD Ltd.
Last refreshed: 11 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04437680.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing